@article {Parke:2005:1938-6478:145,
	author = "Parke, Neil J. and Good, Nanci F. and Meyerhoff, Roger D.",
	title = "CONTROL OF PHARMACEUTICALS AND ANIMAL HEALTH PRODUCTS IN WASTEWATER EFFLUENTS FROM MANUFACTURING SITES",
	journal = "Proceedings of the Water Environment Federation",
	volume = "2005",
	number = "16",
	year = "2005",
	abstract = "In many cases, the discharge of pharmaceuticals and animal health products at bulk manufacturing, fill/finish, development and research operations may not be directly regulated with numeric limitations as a part of a facility's wastewater discharge permit. The biological activity of these discharged compounds, if not properly managed, may have the potential to impact the operation of an onsite or a municipal wastewater treatment plant, aquatic species in streams, rivers, oceans, or a drinking water source. An overview of the Eli Lilly and Company environmental protection program is provided, which shows how potential releases of active ingredients from its operations are managed to protect the environment.",
	pages = "145-155",
	url = "http://www.ingentaconnect.com/content/wef/wefproc/2005/00002005/00000016/art00009",
	doi = "doi:10.2175/193864705783867927"
}